{医疗药品管理}云南白药2.pdfVIP

{医疗药品管理}云南白药 2 本报告期，财务会计报告未经审计。 （一）财务会计报告 资产负债表 编制单位：云南白药集团股份有限公司2009年06月30 日单位：（人民币）元 ,期末余额,年初余额 项目,, ,合并,母公司,合并,母公司 ,,,, 流动资产：,,,, 货币资金,2,767,542,792.51,2,105,588,344.56,2,335,333,994.33,1,701,440,598.98 结算备付金,0.00,0.00,0.00,0.00 拆出资金,0.00,0.00,0.00,0.00 交易性金融资 ,0.00,0.00,0.00,0.00 应收票据,122,106,002.40,71,813,107.98,216,658,630.21,176,735,297.94 应收账款,402,035,273.37,82,159,765.91,161,284,874.55,61,687,049.49 预付款项,94,728,357.06,73,125,337.09,326,616,938.43,342,093,202.96 应收保费,0.00,0.00,0.00,0.00 应收分保账款,0.00,0.00,0.00,0.00 应收分保合同准备金,0.00,0.00,0.00,0.00 应收利息,1,341,622.47,1,026,834.00,1,523,244.03,1,026,834.00 应收股利,0.00,1,682,320.48,0.00,1,682,320.48 其他应收款,206,209,709.77,287,290,840.41,145,380,151.05,236,861,597.63 买入返售金融资 ,0.00,0.00,0.00,0.00 存货,1,278,226,709.76,202,171,389.91,1,301,637,236.42,153,886,259.06 一年内到期的非流动资 ,0.00,0.00,0.00,0.00 其他流动资 ,0.00,0.00,0.00,0.00 流动资产合计,4,872,190,467.34,2,824,857,940.34,4,488,435,069.02,2,675,413,160.54 非流动资产：,,,, 发放贷款及垫款,0.00,0.00,0.00,0.00 可供出售金融资 ,0.00,0.00,2,996,154.00,2,996,154.00 持有至到期投资,0.00,0.00,0.00,0.00 长期应收款,0.00,0.00,0.00,0.00 长期股权投资,36,950,728.94,798,770,059.60,36,336,909.43,803,156,240.09 投资性房地 ,0.00,0.00,0.00,0.00 固定资 ,229,426,563.93,50,436,773.99,238,825,809.62,54,110,926.69 在建工程,81,429,914.81,60,371,215.29,44,898,522.73,30,716,072.09 工程物资,0.00,0.00,0.00,0.00 固定资产清理,0.00,0.00,0.00,0.00 生产性生物资 ,0.00,0.00,0.00,0.00 油气资 ,0.00,0.00,0.00,0.00 无形资 ,378,858,175.81,330,418,379.81,58,871,941.37,23,293,542.76 开发支出,0.00,0.00,0.00,0.00 商誉,12,843,661.62,0.00,12,843,661.62,0.00 长期待摊费用,7,337,257.02,2,452,521.24,5,996,995.80,111,052.82 递延所得税资 ,41,587,966.39,14,276,677.83,37,964,513.97,13,138,361.24 其他非流动资 ,10,035,361.66,35,361.66,10,000,000.00,0.00 非流动